99223-92-4Relevant articles and documents
Potential radiodrugs for adrenal gland scintigraphy, I: Radioiodination of tyramine derivatives of some digitalis aglycones and scillarenin
Roder,Lutz
, p. 837 - 842 (1985)
-
99223-92-4
Post Buying Request-
-
Basic information
- Product Name: (3beta)-14-hydroxy-3-{[2-(4-hydroxyphenyl)ethyl]amino}bufa-4,20,22-trienolide
- Synonyms:
- CAS NO:99223-92-4
- Molecular Formula: C32H41NO4
- Molecular Weight: 503.6722
- EINECS: N/A
- Product Categories: N/A
- Mol File: 99223-92-4.mol
- Article Data: 1
-
Chemical Properties
- Melting Point: N/A
- Boiling Point: 694°C at 760 mmHg
- Flash Point: 373.5°C
- Appearance: N/A
- Density: 1.23g/cm3
- Vapor Pressure: 3.23E-20mmHg at 25°C
- Refractive Index: 1.629
- Storage Temp.: N/A
- Solubility: N/A
- CAS DataBase Reference: (3beta)-14-hydroxy-3-{[2-(4-hydroxyphenyl)ethyl]amino}bufa-4,20,22-trienolide(CAS DataBase Reference)
- NIST Chemistry Reference: (3beta)-14-hydroxy-3-{[2-(4-hydroxyphenyl)ethyl]amino}bufa-4,20,22-trienolide(99223-92-4)
- EPA Substance Registry System: (3beta)-14-hydroxy-3-{[2-(4-hydroxyphenyl)ethyl]amino}bufa-4,20,22-trienolide(99223-92-4)
-
Safety Data
- Hazard Codes: N/A
- Statements: N/A
- Safety Statements: N/A
- WGK Germany:
- RTECS:
- HazardClass: N/A
- PackingGroup: N/A
- Hazardous Substances Data: 99223-92-4(Hazardous Substances Data)
99223-92-4 Suppliers
Recommended suppliersmore
99223-92-4 Usage
Description
(3beta)-14-hydroxy-3-[2-(4-hydroxyphenyl)ethyl]aminobufa-4,20,22-trienolide is a natural bufadienolide compound derived from the Chinese traditional medicine ChanSu. It is characterized by its unique chemical structure and has demonstrated significant anti-cancer properties, making it a promising candidate for further research and development as a potential therapeutic agent for cancer and other diseases.Uses
Used in Pharmaceutical Industry:(3beta)-14-hydroxy-3-[2-(4-hydroxyphenyl)ethyl]aminobufa-4,20,22-trienolide is used as an anti-cancer agent for its ability to induce cell cycle arrest and apoptosis in various cancer cell lines. Its potential anti-inflammatory and anti-angiogenic activities also contribute to its therapeutic potential in treating cancer and other related diseases.
Used in Cancer Research:
(3beta)-14-hydroxy-3-[2-(4-hydroxyphenyl)ethyl]aminobufa-4,20,22-trienolide is utilized in cancer research to explore its underlying mechanisms of action and to identify its potential synergistic effects with other therapeutic agents. This research aims to enhance its efficacy and develop novel drug delivery systems to improve its bioavailability and therapeutic outcomes in cancer treatment.
Check Digit Verification of cas no
The CAS Registry Mumber 99223-92-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,9,2,2 and 3 respectively; the second part has 2 digits, 9 and 2 respectively.Calculate Digit Verification of CAS Registry Number 99223-92:
(7*9)+(6*9)+(5*2)+(4*2)+(3*3)+(2*9)+(1*2)=164
164 % 10 = 4
So 99223-92-4 is a valid CAS Registry Number.
99223-92-4Upstream product
99223-92-4Downstream Products
Post a RFQ
1
What can I do for you?
Get Best Price
Get Best Price for 99223-92-4
(3beta)-14-hydroxy-3-{[2-(4-hydroxyphenyl)ethyl]amino}bufa-4,20,22-trienolide
